Clinical trial Recruiting at 1 site Interventional

Using a protocol to manage antithrombotic medicines around surgery

Official title: Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study

Run by Peking University First Hospital · NCT04852406 · Data updated 2026-11-12

This study will test whether following a specific protocol for managing blood thinners before, during, and after surgery reduces bleeding and clotting complications in people on long-term antithrombotic therapy.

Quick facts

Study typeInterventional
SexAll
Enrollment526 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedApril 21, 2021
Main results expectedDecember 2025
Study endsJanuary 2026
Registry record updatedJuly 31, 2025
Trial IDNCT04852406 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults on chronic antithrombotic therapy (antiplatelet and/or anticoagulant for >2 weeks) with high thrombotic risk (for example high CHA2DS2-VASc, recent valve replacement, recent VTE, recent stent/CABG, or recent stroke) who are planning elective surgery.

Probably not a fit

Patients not taking chronic antithrombotic medications, those with low thrombotic risk, or those needing urgent or emergency surgery are unlikely to benefit from this perioperative protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pragmatic interventional trial randomizes patients on chronic antithrombotic therapy to protocol-based perioperative management versus routine care to compare a composite of perioperative outcomes. Eligible patients are those taking antiplatelet and/or anticoagulant drugs for cardiovascular or cerebrovascular disease and meeting high-risk criteria who are scheduled for surgery. The protocol is based on multidisciplinary guideline and expert-consensus recommendations and standardizes timing of drug withholding, bridging, and resumption. Outcomes include perioperative bleeding, thrombotic events, and other perioperative complications collected at a single tertiary hospital site.

Why it matters

Potential benefit: If successful, the protocol could reduce bleeding and thrombotic complications and make perioperative anticoagulant care safer and more consistent for patients.

How similar studies have gone: Guidelines and expert consensus support protocolized antithrombotic management, but randomized and pragmatic data on clinical outcome benefits are limited and evidence is scarce.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\. Patients with continuing antithrombotic therapy (including antiplatelet and/or anticoagulant therapies) for cardiovascular and cerebrovascular diseases for more than 2 weeks.
* 2\. Patients who have one or more of the following situations: (1) non-valvular atrial fibrillation with a CHA2DS2-VASc score \>4; (2) post-artificial valve replacement (including mitral valve, ball-cage valve or tilting disc aortic valve); (3) venous thromboembolism occurred within 1 year, or venous thromboembolism with other high-risk factors which require long-term anticoagulation treatment; (4) coronary heart disease with coronary stent implantation, thrombolytic therapy or other coronary procedures within 2 years, or who had undergone coronary artery bypass grafting within 1 year, or who experienced myocardial infarction or acute coronary syndrome within 1 year; (5) a history of stroke/transient ischemic accident within 1 year, or a history of cervical or intracranial revascularization treatment within 1 year; (6) peripheral arterial disease.
* 3\. Patients who are scheduled to undergo intra-abdominal surgery (including general and urologic surgery).
* 4\. Patients who sign written informed consents.

Exclusion Criteria:

* 1\. Refuse to participate.
* 2\. Emergency surgery.
* 3\. Unable to complete the preoperative assessment and follow-up plan.
* 4\. Other reasons that are considered unsuitable for study participation by the investigators or the attending doctors.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.